Alantolactone enhances the sensitivity of melanoma to MAPK pathway inhibitors by targeting inhibition of STAT3 activation and down-regulating stem cell markers
2024 · Cancer Cell International · 7 citations
https://doi.org/10.1186/s12935-024-03371-9
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
3
Papers
10
Citations
2
h-index
0
i10-index
Xinzhi Dai is an academic researcher from Zunyi Medical University. The author has contributed to research in topics: Synthesis and biological activity & Melanoma and MAPK Pathways & Cancer Cells and Metastasis. The author has an h-index of 2, co-authored 3 publications.
ORCID: 0009-0006-2283-4163Click to start Chat